Schedule 13G ownership disclosure
Tenaya Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 87990A106
Event date: 2025-02-28
- Filing-level shares
- 2,283,914.0
- Percent of class
- 2.8%
- JPMORGAN CHASE & CO.
Shares: 2,283,914.0 · Class: 2.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000019617-25-000297
- Form type
- SCHEDULE 13G/A
- Filer
- JPMORGAN CHASE & CO
- CIK
- CIK 19617
- Filed
- Mar 06, 2025
- Reporting period
- Feb 28, 2025
- Description
- Schedule 13G beneficial ownership